The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles

China Medical University

Status and phase: Unknown; Phase 3

Conditions: Hyperlipidemia

Treatments: Drug: Lipid-lowing Tea

Study type: Interventional

Funder types: Other

Identifiers

NCT00316641

DMR93-IRB-71

Details and patient eligibility

About

The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe in the treatment of Hyperlipidemia Patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient aged 20-65 years;either sex
• Patient diagnosed with hyperlipidemia(fasting levels of TC>=200mg/dL),or TG>=200mg/dL but <400mg/dL,or LDL-C>=130mg/dL)
• Patient who has signed the informed consent form

Exclusion criteria

• Patient with pregnancy (or child bearing potential),or in lactation
• Patient with any lipid regulating agents within 4 weeks prior to study period
• Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, β-blockers, cyclosporins, itraconazole erythromycin,and danazol)
• Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis.
• Patient with liver dysfunction (SGOT or SGPT>2x ULN)
• Patient with renal insufficiency (serum creatinine>1.3mg/dL)
• Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.